Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Zyus Life Sciences Corporation V.ZYUS

Alternate Symbol(s):  ZLSCF

Healthcare Drug Manufacturers - Specialty & Generic
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal... see more

Current News (TSXV:ZYUS)

ZYUS Life Sciences Provides Update on Clinical Trial Progress and Unit Private Placement

Canada NewsWire 3 days ago

ZYUS Life Sciences Announces Grant of Stock Options and Deferred Share Units

Canada NewsWire 9 days ago

ZYUS Life Sciences Corporation Announces Closing of First Tranche of Unit Offering and Issuance of Warrants Pursuant to Previously Announced Loan Agreements and Promissory Note Amendment

Canada NewsWire November 7, 2025

ZYUS Life Sciences Corporation Announces Closing of Additional Secured Loan

Canada NewsWire October 20, 2025

ZYUS Life Sciences Corporation Announces Closing of Secured Loan and Amendments to Prior Secured Promissory Note

Canada NewsWire October 17, 2025

ZYUS Life Sciences Announces Activation of Two Additional Clinical Sites in Phase 2a UTOPIA-1 Cancer Pain Trial

Canada NewsWire October 2, 2025

ZYUS Life Sciences Activates First Clinical Site and Enrolls First Patient in Phase 2a UTOPIA-1 Cancer Pain Trial

PR Newswire August 26, 2025

ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering

Canada NewsWire August 15, 2025

ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering

Canada NewsWire July 29, 2025
View More News ››

Opinion & Analysis (TSXV:ZYUS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:ZYUS)

test

Blacknite4 - April 15, 2025
View more Bullboard ››

Alvopetro Energy Ltd.

Alvopetro Energy Ltd.

Alvopetro Energy Ltd. engages in the acquisition, exploration, development, and production of hydrocarbons in Brazil and ...
View More »